Related Experiment Video
Updated: Feb 10, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Clinical implementation of psychiatric pharmacogenomic testing
1Mayo Clinic, Department of Psychiatry and Psychology, 200 First Street, SW Rochester, Minnesota 55905, USA;;E-mail: . mrazek.david @mayo.edu.
Abstract:
For the past 5 years, many investigators have suggested that psychiatrists are on the verge of using genotyping to guide clinical psycho-pharmacological practice. After much anticipation, the first applications of this new technology are being used to select psychotropic medication and inform individual variation in the appropriate dose of medication. Not surprisingly, the drug-metabolizing enzyme genes have been the first genes to be clinically genotyped for psychiatric practice.
More Related Videos
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

